You searched for "virtual"
Orbital cellulitis outcomes for children
This paper discusses the clinical profile and multidisciplinary team (MDT) management outcomes in children treated for paediatric orbital cellulitis. This was a prospective study of 40 children with a mean age of 7.5 years (4-12). Unilateral orbital cellulitis cases had...
Using MRI to assess normal variation in optic chiasm anatomy
The authors present an MRI study including 61 MRI scans using a 1.5 T with slice thickness of 1 or 5mm and the sequence showing the highest resolution of the chiasm. A predetermined set of measurements were taken in a...
Refraction under GA in children using cycloplegic refraction as a reference
The authors aimed to compare the measurements of cycloplegic refraction and refraction (R1-1) under general anaesthesia (GA) with automated refraction (ARF) in paediatric patients and to determine the impact of GA on accommodation. The study included 222 eyes of 222...
Retrospective safety assessment of apraclonidine for diagnosis of Horner’s syndrome in children
Apraclonidine has been shown to reverse the anisocoria in Horner’s syndrome, with some reports of partial ptosis resolution. Side-effects of apraclonidine have been reported especially in children under six months old. The authors present a retrospective safety study of using...
Combined versus traditional photocoagulation treatment for aggressive posterior retinopathy of prematurity (APROP)
The purpose was to report the outcomes of the combined treatment of sparing laser photocoagulation and intravitreal Bevacizumab (IVB) treatment versus conventional laser photocoagulation intervention in APROP. This was a study of 18 eyes of nine infants. One was excluded...
Intermittent manual compression for CCF
Carotid cavernous fistulae (CCF) can be classified as high and low-flow or as having direct and indirect communication. Most commonly, management of high-flow CCF is with endovascular embolisation. The authors look at an alternative treatment for CCF in indirect low-flow...
Oxymetazoline hydrochloride for improved symmetry in Graves’ disease
Oxymetazoline hydrochloride 0.1% ophthalmic solution has Food & Drug Administration (FDA) approval for use in involution ptosis. It is an alpha 1 agonist and partial alpha 2 agonist that stimulates Muller’s muscle to lift the lid. The authors of this...
